⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22198624 | 0.68 | — | — | |
| SCHEMBL20989243 | 0.66 | — | — | |
| SCHEMBL25097313 | 0.64 | — | — | |
| SCHEMBL21096910 | 0.63 | — | — | |
| SCHEMBL21340328 | 0.63 | — | — | |
| SCHEMBL29326635 | 0.61 | — | — | |
| SCHEMBL27740079 | 0.61 | — | — | |
| SCHEMBL25851149 | 0.61 | — | — | |
| SCHEMBL12445439 | 0.61 | — | — | |
| SCHEMBL22343584 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676802-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2017-06-13 | — | — | US | disclosed |